US Dermatology OTC Medications Market Key Players and Forecast by 2028

Historic Data: 2018-2019 | Base Year: 2020 | Forecast Period: 2021-2028

US Dermatology OTC Medications Market Forecast to 2028 - COVID-19 Impact and Country Analysis By Product Type (Tablets and Capsules, Oils, Gels, Creams and Ointments, Others); Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Anti-Fungal, Wart Remover, Others); Route of Administration (Topical, Oral); Distribution Channel (Online Distribution, Hospital and Retail Pharmacies, Super and Hyper Markets)

Report Date : Apr 2021
Report Code : TIPRE00022065

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 140

Page Updated: Mar 2023

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The US dermatology OTC medications market was valued at US$ 952.97 million in 2020 and is projected to reach US$ 1,124.56 million by 2028; it is expected to grow at a CAGR of 2.1% during 2021–2028.

The growth of the market is attributed to rising prevalence of skin abnormalities and increasing availability of dermatology medication over the counter (OTC). However, the side effects associated with OTC dermatology medication such as skin allergy hinder the growth of the market.

The US dermatology OTC medications market is expected to witness significant growth during the forecast period. The growth of the market is expected to be fastest due to rising prevalence of skin abnormalities and increasing availability of dermatology medication over the counter (OTC). For instance, as per to the American Academy of Dermatology Association, acne is the most common skin condition in the US, affecting ~50 million Americans annually. ~85% of people from the age group of 12–24 experience minor acne problems. Additionally, the COVID-19 has affected a large population in the US leading to an unprecedented surge in demand for popular OTC drugs. Consumers appear to be trying to address illness symptoms on their own, to avoid visiting clinic. Physical distancing and stay-at-home orders have forced consumer to shop differently. Also, continuous use of mask and constant handwashing has led to skin irritation, and maskne. Constant handwashing has led to increase in conditions such as skin dryness and eczema, this has led to increase in demand for dermatology OTC products.

US Dermatology OTC Medications Market Revenue and Forecast to 2028 (US$ Million)

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

US Dermatology OTC Medications Market Segmentation

By Product Type

Tablets and Capsules
Oils
Gels
Creams and Ointments
Others

By Indication

Dermatitis
Acne
Psoriasis
Skin Bleaching
Anti-Fungal
Wart Remover
Others

By Route of Administration

Topical
Oral

By Distribution Channel

Online Distribution
Hospital and Retail Pharmacies
Super and Hyper Markets

Company Profiles

Bausch Health Companies Inc
Perrigo Company Plc
Bayer AG
Viatris Inc.
Johnson and Johnson Services, Inc.
LEO Pharma A/S
GlaxoSmithKline Plc.
Galderma
Dr. Reddy's Laboratories
Acella Pharmaceuticals, LLC

US Dermatology OTC Medications Report Scope

Report Attribute	Details
Market size in 2020	US$ 952.97 Million
Market Size by 2028	US$ 1,124.56 Million
CAGR (2021 - 2028)	2.1%
Historical Data	2018-2019
Forecast period	2021-2028
Segments Covered	By Product Type Tablets and Capsules Oils Gels Creams and Ointments By Indication Dermatitis Acne Psoriasis Skin Bleaching Anti-Fungal Wart Remover By Route of Administration Topical Oral By Distribution Channel Online Distribution Hospital and Retail Pharmacies Super and Hyper Markets
Regions and Countries Covered	United State United State
Market leaders and key company profiles	Bausch Health Companies Inc Perrigo Company Plc Bayer AG Viatris Inc. Johnson and Johnson Services, Inc. LEO Pharma A/S GlaxoSmithKline Plc. Galderma Dr. Reddy's Laboratories

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the US Dermatology OTC Medications Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

RAN KEDEM Partner, Reali Technologies LTDs

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

JEAN-HERVE JENN Chairman, Future Analytica

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

JOHN SUZUKI President and Chief Executive Officer, Board Director, BK Technologies

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

Reason to Buy